Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
Condition(s) studied
Investigational drug(s) / intervention(s)
Infant formula and follow-on formula made from whole goat milk: Infant formula and follow-on formula made from whole goat milk
Infant formula and follow-on formula made from cow's milk ingredients: Infant formula and follow-on formula made from cow's milk ingredients
Study summary
To determine the relative risk of developing atopic dermatitis in infants fed a study formula based on whole goat milk compared to infants a study formula based on cow milk protein.
Eligibility
Primary outcome measure(s)
- Cumulative incidence of atopic dermatitis up to the age of 12 months — Age 12 months
Cumulative incidence of atopic dermatitis up to the age of 12 months diagnosed by study personnel (defined as meeting the UK Working Party Diagnostic Criteria for atopic dermatitis)
Trial sites (12)
| Facility | City | Region | Status |
|---|---|---|---|
| Dr. von Hauner Children's Hospital, LMU University Hospital Munich | Munich | Germany | |
| Wojewodzki Specjalistyczny Szpital Dzieciecy | Olsztyn | Poland | |
| Karol Jonscher's University Hospital | Poznan | Poland | |
| Medical College of Rzeszow University | Rzeszów | Poland | |
| Children's Memorial Health Institute | Warsaw | Poland | |
| Unit of Pediatric Gastroenterology and Nutrition, Torrecardenas University Hospital | Almería | Spain | |
| EURISTIKOS Excellence Centre for Paediatric Research, University of Granada | Granada | Spain | |
| Department of Neonatology, Hospital Universitario La Paz | Madrid | Spain | |
| Hospital Universitari Sant Joan de Reus | Reus | Spain | |
| Hospital Universitari Joan XXIII de Tarragona | Tarragona | Spain | |
| INCLIVA Health Research Institute | Valencia | Spain | |
| Hospital Clinico Universitario Lozano Blesa, Instituto de investigacion Sanitaria de Aragon | Zaragoza | Spain |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04599946 on ClinicalTrials.gov ↗ ← All trials in Poland